Press Releases

January 8, 2024 Lupin Launches Second Edition of Aptivate Champion Run for Kids Promoting Children’s Well-being Through Fitness and Nutrition

January 4, 2024 Lupin Receives Tentative Approval from U.S. FDA for Dapagliflozin and Saxagliptin Tablets

December 27, 2023 Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Suspension, 0.2%

December 21, 2023 Lupin Launches Softovac Liquifibre, a first-of-its-kind liquid fibre

December 15, 2023 Lupin Receives Approval from U.S. FDA for Allopurinol Tablets

December 15, 2023 Lupin Receives Tentative Approval from U.S. FDA for Sitagliptin Tablets

December 14, 2023 Lupin Diagnostics Expands Presence in South India with New Regional Reference Laboratory in Chennai

December 6, 2023 Lupin Receives Approval from U.S. FDA for Varenicline Tablets

December 1, 2023 Lupin Launches Turqoz^®(Norgestrel and Ethinyl Estradiol) Tablets USP in the United States